Clinical Study Enrollment 10/1/19

Leonhardt’s Launchpads

Patients Enrolled in Clinical Studies by Startup
as of October 1, 2019

  • Second Heart = 4 pts Paraguay
  • OrthodontiCell = 47 pts Brazil
  • MyoStim ED = 73 pts Brazil + South Africa
  • HairCell = 12 pts South Africa
  • EyeCell = 176 pts USA
  • PressureStim = 65 pts China/UC Irvine + 11 Korea + 13 Brazil
  • BladderCell = 56 pts Brazil
  • Stem Cell Bra = 6 pts South Africa & Brazil
  • SkinStim = 10 pts South Africa
  • TestiStim = 1 pt USA
  • KidneyCell = 21 pts Brazil
  • Valvublator = 1 pt Italy surgical
  • DentaCell = 100 pts + USA
  • InStim = 1 pt Brazil
  • OrthoStim/Tisugen = 10 pts USA Santa Rosa (301 pt study completed in China by a group we are reaching out to collaborate with)
  • Vascustim = 7 pts Mexico + 16 pts Czech Republic + 47 pts Wetling Switzerland, Denmark and Germany

Total = 724

We are working to close partnership agreements with groups that have completed successful bioelectric or biologics based (or both) clinical studies for brain recovery, cancer, liver, lungs, knees (300+) which if all are concluded would increase patient count in clinic studies by > 1000 more.